Chronic myeloid leukemia (CML) is a hematologic malignancy that originates from a clonal proliferation of bone marrow hematopoietic stem cells, characterized by an oncogenic Philadelphia (Ph) chromosome carrying the BCR-ABL1 fusion gene (1). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.